Citeline Podcasts
Episodes
Scrip's Five Must-Know Things - 5 November 2024
05 Nov 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 1 November 2024. In this episode: Lilly plans DTC tirzepa...
【3分で解説 世界のファーマ】第22回 AD治療、費用対効果に悩む英国 (Japanese-language podcast)
29 Oct 2024
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
Scrip's Five Must-Know Things - 28 October 2024
28 Oct 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 25 October 2024. In this episode: Merck & Co’s Modifi a...
Conference Catch-Up: The Rise of Digital Therapeutics (Part 2)
26 Oct 2024
Contributed by Lukas
Health technologies are revolutionizing the ways in which life sciences organizations develop and deliver life-saving treatments to patients. In parti...
October 2024 Datamonitor Healthcare Podcast: Insights from ESMO
21 Oct 2024
Contributed by Lukas
Emma and Summer meet with oncology analysts Neha Anand, Anna Simmons, and Nkiru Ibeanu, to share insights from the European Society of Medical Oncolog...
Scrip's Five Must-Know Things - 21 October 2024
21 Oct 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 18 October 2024. In this episode: J&J looks to Tremfya as...
Drug Fix: SubQ Drugs And Price Negotiations, GLP-1s In Court, US FDA Approach To Black Box AI
18 Oct 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss an emerging pharma strategy to avoid Medicare price negotiations (:25), legal wrangling related to compounding...
빅파마가 직면한 세포유전자 치료제 시장의 현실 (Korean-language podcast)
17 Oct 2024
Contributed by Lukas
빅파마들은 세포유전자 치료제를 출시하면서 이러한 치료의 비용과 복잡성이라는 현실적인 문제에 직면해 있습니...
China Biopharma Podcast - 16 October 2024 (Chinese language)
16 Oct 2024
Contributed by Lukas
Dexter Yan回顾了他在国庆长假前和阿斯利康全球执行副总裁-生物制药研发负责人Sharon Barr的采访。此外，本期播客迎...
Scrip's Five Must-Know Things - 15 October 2024
15 Oct 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 11 October 2024. In this episode: making cell and gene th...
Drug Fix: Inside Medicare Price Negotiations, New US FDA Vaccine Pathway
11 Oct 2024
Contributed by Lukas
Introduction: Pink Sheet reporter and editors discuss experts’ experience helping drug sponsors negotiate prices with CMS (:33) and the FDA’s prop...
Q&A Session on Psoriasis in Pediatric Patients with Dr. Valerie Welch
11 Oct 2024
Contributed by Lukas
Join us for a discussion on pediatric psoriasis and the importance of collaboration across specialties to improve treatment outcomes.
COPD Treatment Strategies: Q&A with Dr. Kenneth Chinsky
11 Oct 2024
Contributed by Lukas
Join us for a discussion on COPD and inhaler choice.
Noticing Neffy – A ‘Transformative Treatment’ For Type 1 Allergies
08 Oct 2024
Contributed by Lukas
Richard Lowenthal, co-founder, and CEO of ARS Pharma, highlights the crucial unmet need for needle-free injections. Challenging issues posed by curren...
Alpha-Synuclein Testing Comes of Age
04 Oct 2024
Contributed by Lukas
In the latest episode of the In Vivo podcast, Russ Lebovitz, the co-founder and scientist behind Amprion, a diagnostics company, discusses the role of...
Q&A Session: PIK3CA Mutations and Breast Cancer
03 Oct 2024
Contributed by Lukas
Join us for an informative discussion about PIK3CA testing and treatment with Dr. Neil Iyengar
Conference Catch-Up: LSX World Congress USA 2024
02 Oct 2024
Contributed by Lukas
Discover the game-changing insights from the LSX World Congress USA! Join Janelle Hart, Managing Editor at Citeline, a Norstella Company, as she expl...
The Future Of Drug R&D Is Self-Driving
30 Sep 2024
Contributed by Lukas
In the latest episode of the In Vivo podcast, Alan Aspuru-Guzik, a pioneer in chemical engineering who holds many positions, talks about how he is fol...
Drug Fix: Pfizer Pulls Sickle Cell Drug, ODAC Calls Back Approved Products, New AAM CEO
27 Sep 2024
Contributed by Lukas
Pink Sheet reporters and editors discuss Pfizer’s abrupt decision to withdraw Oxbryta (:32), the US FDA’s Oncologic Drugs Advisory Committee bring...
Challenges in the Development and Manufacturing of ADCs
24 Sep 2024
Contributed by Lukas
In this podcast, Andrew Warmington, Manufacturing Editor, Citeline, joins together with industry experts, Simone Secchi, R&D Process Chemist, Olon Gro...
September 2024 Datamonitor Healthcare Podcast: Radiopharmaceutical Usage is Heating Up
19 Sep 2024
Contributed by Lukas
Emma Wille chats with oncology team director Dana Gheorghe, PhD, about the resurgence of radiopharmaceutical therapies in oncology. Other platforms (...
Health-Related Quality of Life Considerations In Clinical Trials
16 Sep 2024
Contributed by Lukas
In this podcast, Janelle Hart, Managing Editor at Citeline, teams up with industry experts Mai Yee Mishir, Senior Director of Global Regulatory Affair...
Over the Counter: Data Tech CEO On Digital Tools Driving Faster, More Sustainable Personal Care
13 Sep 2024
Contributed by Lukas
In this episode, HBW chats with Neil D’Souza, CEO of Makersite GmbH, a Stuttgart, Germany-based data software company that offers product data manag...
Drug Fix: US FDA Worries About Celebs Endorsing Drugs, Post-Chevron Lawsuits Emerging
13 Sep 2024
Contributed by Lukas
Introduction: Pink Sheet reporter and editor discuss the FDA’s latest advertising enforcement letter, which targeted a migraine treatment TV commerc...
September 2024 Datamonitor Healthcare Podcast: Diving into the TME
13 Sep 2024
Contributed by Lukas
Emma and Summer meet with oncology analyst Flora to discuss the therapeutic potential of exploring the tumor microenvironment. Apple Podcasts - h...
The Generics Bulletin Podcast: Recent And Upcoming Industry Events
12 Sep 2024
Contributed by Lukas
Generics Bulletin's editorial team discusses recent conferences held by Medicines for Europe and the AAM, while looking ahead to the key off-patent in...
【3分で解説 世界のファーマ】第21回 中国企業 日本で続々治験開始へ (Japanese-language podcast)
10 Sep 2024
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
J&J, '차별화된' 비만 자산에 관심있어 (Korean-language podcast)
09 Sep 2024
Contributed by Lukas
호아킨 두아토 존슨앤존슨 대표가 모건스탠리 헬스케어 컨퍼런스에서 발표한 내용입니다. https://scrip.citeline.com/SC...
Scrip's Five Must-Know Things - 9 September 2024
09 Sep 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 September 2024. In this episode: J&J interested in diff...
Drug Fix: Pediatric Rare Disease PRV Deadline Approaches, Potential Makena Compounding Ban
06 Sep 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss the potential fallout if the US FDA’s rare pediatric disease priority review voucher program is allowed to s...
Scrip's Five Must-Know Things - 2 September 2024
02 Sep 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 30 August 2024. In this episode: summer ADC dealmaking co...
Drug Fix: New US FDA Developments In AI Regulation
30 Aug 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss new developments in the FDA’s plans to regulate artificial intelligence and drugs associated with it, includ...
Digital Health Roundup: Digital Therapeutics Navigate GLP-1, Gaming; DHCoE On AI; Hello Heart
29 Aug 2024
Contributed by Lukas
In this week’s Digital Health Roundup, Medtech Insight’s Ryan Nelson highlights Click Therapeutics’ FDA-cleared digital therapeutics (DTx) for d...
Exploring The Postbiotic Opportunity In Consumer Health, With Kerry’s Sonja Nodland
27 Aug 2024
Contributed by Lukas
Interest in the human gut microbiome and the influence it exerts on a person’s wellbeing, from cognitive health to immunity, has been rapidly increa...
Scrip's Five Must-Know Things - 26 August 2024
26 Aug 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 23 August 2024. In this episode: CMS’s price reveal bet...
August 2024 Datamonitor Healthcare Podcast: The Colorful Landscape of Therapeutic Psychedelics
22 Aug 2024
Contributed by Lukas
Following the recent FDA rejection of MDMA therapy for PTSD, Emma and Flora discuss the future role of psychedelics in the treatment of mental health ...
Bioprinting – An Innovative Tool That Is Revolutionizing Drug Discovery
19 Aug 2024
Contributed by Lukas
Keith Murphy, co-founder of Organovo, discusses the growing potential of bioprinting and how the company is using its technologies to study and develo...
Scrip's Five Must-Know Things - 19 August 2024
19 Aug 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 August 2024. In this episode: Merck & Co. steps into C...
Drug Fix: What We Learned From The First Batch Of Medicare Negotiated Drug Prices
16 Aug 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss the take-aways from the landmark first Medicare negotiated drug prices and what additional information remains...
【3分で解説 世界のファーマ】第20回 欧州心臓病学会 注目の新薬候補は (Japanese-language podcast)
15 Aug 2024
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
Sustainable By Design: Thermo Fisher's Meron Mathias On ESG Compliance And The Competitive Edge
14 Aug 2024
Contributed by Lukas
Compliance with environmental sustainability goals is no longer optional for medtech companies serving global healthcare markets. Thermo Fisher has ma...
Scrip's Five Must-Know Things - 13 August 2024
13 Aug 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 9 August 2024. In this episode: Amgen positions for obesi...
Why Purpose Is Key To Driving CHC Growth, With Haleon’s Bas Vorsteveld
12 Aug 2024
Contributed by Lukas
Since becoming a standalone consumer health company, Haleon has been driving awareness of public health issues such as chronic pain and children’s o...
Drug Fix: Clinical Trial Diversity, Off-Label Standard Of Care Issues, In-Person US FDA Adcomms
09 Aug 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss former Surgeon General Jerome Adams’ views on how the FDA can better ensure clinical trial diversity (:27), ...
Type 2 Diabetes and SGLT2 Inhibitors Q&A
09 Aug 2024
Contributed by Lukas
In this audio, Dr. Anthony Fritz discusses Type 2 diabetes and the benefits of SGLT2 inhibitors. Learn how this treatment option can improve diabetes ...
비만치료제, 2024년 상반기 대형주를 지배하다 (Korean-language podcast)
07 Aug 2024
Contributed by Lukas
올해 상반기 일라이 릴리와 노보 노디스크의 주가가 가장 높은 상승세를 보인 반면, BMS와 길리어드의 주가는 가장...
Scrip's Five Must-Know Things - 5 August 2024
05 Aug 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 2 August 2024. In this episode: Pfizer bullish on its ora...
Drug Fix: August User Fee Goals, Oncology Trial Design Issues, EMA Review Changes
02 Aug 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss the US FDA drug approval decisions that could arrive in August (:34), a trial design issue that could ensnare ...
China Biotech Podcast - 2 August 2024 (Chinese language)
02 Aug 2024
Contributed by Lukas
RNK Pharma founder and CEO Yaning Wang joins Brian Yang to discuss Shanghai's latest biopharma stimulus policies and the globalization of China biotec...
July 2024 Datamonitor Healthcare Podcast: The Future of Biologics in COPD
31 Jul 2024
Contributed by Lukas
COPD expert Wen-Yu discusses what the entrance of biologics might mean for the COPD treatment landscape and shares a sneak peek from her upcoming pati...
Q&A Session on the Treatment of Multiple Myeloma
29 Jul 2024
Contributed by Lukas
Join us for an insightful Q&A session on the treatment of multiple myeloma with Oncologist Dr. Joshua Richter. In this video, Dr. Richter shares his e...
How To Make An Impact With Your OTC Brand, With PA Consulting’s Rhea Patten
29 Jul 2024
Contributed by Lukas
Consumers are expecting more and more from health and wellness brands, PA Consulting’s latest Brand Impact Index shows. Consumer health brands that ...
Scrip's Five Must-Know Things - 29 July 2024
29 Jul 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 26 July 2024. In this episode: Narasimhan plays the long ...
Drug Fix: US FDA Device Director Retires, PBM Execs On Capitol Hill, Voucher Program Renewal Push
26 Jul 2024
Contributed by Lukas
Editors from the Pink Sheet and Medtech Insight discuss the retirement of Jeff Shuren (:35), PBM executives again appearing unscathed after another Ca...
The Exciting Future of Heart Failure Management
26 Jul 2024
Contributed by Lukas
Join Victoria Bradley and Dr. Andrew Freeman as they discuss the latest advancements in heart failure treatment, from innovative therapies to the role...
Early Detection Key in COPD Management (Q&A with Brittany Little, NP)
26 Jul 2024
Contributed by Lukas
This Q&A session emphasizes early diagnosis of COPD for better lung function preservation and disease control. It explores COPD symptoms, diagnosis to...
Digital Health Roundup: Brain Talk; Medtronic’s Digital Tech Report OR; UK Guidance
23 Jul 2024
Contributed by Lukas
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights AI discussions at the HLTH Europe conference and an interview wit...
Scrip's Five Must-Know Things - 22 July 2024
22 Jul 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 July 2024. In this episode: J&J’s Spravato on track ...
Medtech Connect 16: AI For Cross Border Regulation
20 Jul 2024
Contributed by Lukas
In this episode, Medtech Insight senior reporter Hannah Daniel speaks to DJ Fang, chief operating officer and co-founder of Pure Global. Pure Global u...
Drug Fix Special: Why The US Approves Most New Drugs Before The EU
19 Jul 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss the impact of a US and EU drug approvals analysis that found the US FDA still clears many novel products first...
국내 AI 신약개발, 선진국과 격차 줄이려면? (Korean-language podcast)
16 Jul 2024
Contributed by Lukas
신테카바이오 조해경 사장은 Scrip과의 인터뷰에서 국내 AI 신약 개발 현황을 글로벌 흐름와 비교하고, 국내외 경...
The Importance of Exploring Genetic Potential
16 Jul 2024
Contributed by Lukas
Discover the key considerations critical to the genetic analysis for advanced therapies, including qPCR and dPCR. Don’t miss expert insights from Ch...
Scrip's Five Must-Know Things - 16 July 2024
16 Jul 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 12 July 2024. In this episode: Q1’s top 10 drugs; Pfize...
EPR Consultant Urges Producers To Start Collecting Packaging Data
12 Jul 2024
Contributed by Lukas
In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended produ...
Improving Communication: The Relationship Between Biotech And Biopharma
10 Jul 2024
Contributed by Lukas
Improving Communication: The Relationship Between Biotech And Biopharma by Citeline
【3分で解説 世界のファーマ】第19回 FDA「密な面談」を企業に呼び掛け (Japanese-language podcast)
09 Jul 2024
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
Scrip's Five Must-Know Things - 8 July 2024
08 Jul 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 5 July 2024. In this episode: US approval for Lilly’s A...
Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead
05 Jul 2024
Contributed by Lukas
Scrip's Joseph Haas, Mandy Jackson and Kevin Grogan discuss the biopharma dealmaking environment as we reach the midpoint of 2024. Haas reviews dealma...
Non-Invasive Solutions: Exploring The Role Of Breath Biopsies In Early Detection
05 Jul 2024
Contributed by Lukas
In this episode of the In Vivo podcast, Billy Boyle, CEO of Owlstone Medical, discusses how his company is developing several breath biopsy products f...
In Vivo Podcast Episode with Stefan Woxström
02 Jul 2024
Contributed by Lukas
In Vivo Podcast Episode with Stefan Woxström by Citeline
How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz
01 Jul 2024
Contributed by Lukas
Aspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and wh...
Scrip's Five Must-Know Things - 1 July 2024
01 Jul 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 June 2024. In this episode: global CEO remuneration; a...
Drug Fix: What’s In And Out Of US FDA’s Diversity Action Plan Guidance, AI Guidance Also Coming
28 Jun 2024
Contributed by Lukas
Pink Sheet reporter and editors discuss what the FDA included in its long-awaited guidance on clinical trial diversity action plans, along with what w...
China Biotech Podcast - 26 June 2024 (Chinese language)
26 Jun 2024
Contributed by Lukas
Guest speaker “Angus” Shipo Xie of Hankun Law joins Brian Yang to discuss new overseas data transfer rules, while Dexter Yan explains China biotec...
Scrip's Five Must-Know Things - 24 June 2024
24 Jun 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 June 2024. In this episode: the outlook for 2025 launc...
Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB
21 Jun 2024
Contributed by Lukas
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technol...
The Power Of Herbs For Women’s Wellness, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley
17 Jun 2024
Contributed by Lukas
In this episode, HBW Insight chats with women’s health start-up The SABI about the power of herbal medicine for hormonal wellness. “Inspired by a ...
Scrip's Five Must-Know Things - 17 June 2024
17 Jun 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 14 June 2024. In this episode: Boehringer best in MASH?; ...
Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond
14 Jun 2024
Contributed by Lukas
In this podcast, Janelle Hart, Managing Editor, Citeline, joins industry experts Jessica Wall, Director of Talent Acquisition, and Morgan Seaman, Asso...
June 2024 Datamonitor Healthcare Podcast: ASCO 2024
14 Jun 2024
Contributed by Lukas
The oncology team from Datamonitor Healthcare and healthcare journalist, Alaric, provide broad analytical coverage of key highlights from the ASCO 202...
China Biotech Podcast - 14 June 2024 (Bilingual Chinese/English)
14 Jun 2024
Contributed by Lukas
Guest speaker, US-based Pink Sheet senior writer Sarah Karlin-Smith, joins Brian Yang and Dexter Yan in China to discuss the recent BIO Conference, up...
ASCO 결산: 암 연구의 미래는? (Korean-language podcast)
13 Jun 2024
Contributed by Lukas
글로벌 제약업계는 암 연구의 미래를 어떻게 보고 있을까? Scrip의 ASCO 현장 취재 기사를 요약한 내용입니다. https:...
Scrip's Five Must-Know Things - 10 June 2024
10 Jun 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 June 2024. In this episode: BIO Notebook; ASCO roundup;...
The Generics Bulletin Podcast: Teva, Sandoz, Sawai and US Orange Book patents
07 Jun 2024
Contributed by Lukas
Generics Bulletin's editorial team discusses the latest strategic developments for major industry players Teva, Sandoz and Sawai, as well as explainin...
China Biotech Podcast - 5 June 2024 (Chinese language)
05 Jun 2024
Contributed by Lukas
Guest speaker Guangzuo Luo, chief scientific officer of Bioncetech, joins China-based editors Brian Yang and Dexter Yan in this episode, which looks a...
JB CEO On CDMO Growth, Red Sea Crisis And More
04 Jun 2024
Contributed by Lukas
In an interview with Scrip, JB CEO Nikhil Chopra addresses rumours of a sale of a stake in the Indian pharma/CDMO company by private equity fund KKR, ...
Scrip's Five Must-Know Things - 3 June 2024
03 Jun 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 31 May 2024. In this episode: ASCO preview; Asahi’s US ...
The Scrip Awards Podcast. Episode 1: Genmab: The Ongoing Evolution Of Europe’s Antibody Powerhouse
31 May 2024
Contributed by Lukas
An interview with Genmab’s Jan van de Winkel to mark 25 years of the company, and 20 years of the Scrip Awards. A brief history of the antibody-foc...
How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone
31 May 2024
Contributed by Lukas
In this episode we unpack the Corporate Sustainability Reporting Directive (CSRD) with the help of ESG expert Jasper Crone, drilling down into exactly...
Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions
31 May 2024
Contributed by Lukas
Advancing Investigational New Drugs (INDs) can be a complex process, especially for smaller companies. Listen to your free podcast now as Marcus Delat...
'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovation
29 May 2024
Contributed by Lukas
Astellas Pharma’s chief commercial officer, Claus Zieler, discusses the biopharma industry’s responsibility to drive change in health care.
China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen
28 May 2024
Contributed by Lukas
NeuShen CEO Joan Shen discusses with Brian Yang about developing CNS drugs in China, the venture's business rationale, challenges and fundraising. She...
Citeline Japan Awards 2024 - Enter Now! (Bilingual English/Japanese)
28 May 2024
Contributed by Lukas
As the 15 July entry deadline for the 3rd edition of the annual Citeline Japan Awards approaches, join us in this bilingual English/Japanese podcast t...
Scrip's Five Must-Know Things - 27 May 2024
27 May 2024
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended 24 May 2024. In this episode: Biogen’s immunology acqui...
Drug Fix: Novel Clinical Trial Reg Problems, NIH Drug ‘Access Plans’, Good Ole Days Of Woodcock
24 May 2024
Contributed by Lukas
Pink Sheet editors discuss the US FDA’s consideration of regulatory changes to promote innovative clinical trial designs (:32), an NIH proposal to r...
【3分で解説 世界のファーマ】第18回 GLP-1を超える肥満治療薬のカギとは？(Japanese-language podcast)
23 May 2024
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing
22 May 2024
Contributed by Lukas
In this episode of the In Vivo podcast, Hakim Yadi, CEO and co-founder of UK techbio company Closed Loop Medicine, discusses how his company is pairin...
Leading PRO Discusses Plans For Administering State EPR Programs
21 May 2024
Contributed by Lukas
In this episode, HBW chats with John Hite of the leading producer responsibility organization administering three Extended Producer Responsibility law...
개발 VS 딜메이킹: 블록버스터 신약을 확보하는 방법 (Korean-language podcast)
21 May 2024
Contributed by Lukas
빅파마 기업들의 블록버스터 신약 확보 전략에 대한 Scrip 기사를 요약한 내용입니다. https://scrip.citeline.com/SC150256/D...
How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane
20 May 2024
Contributed by Lukas
In this episode, HBW Insight catches up with Albert Swane, founder and CEO of Dutch consumer healthcare firm, TheOTCLab, to talk about business strate...